{"id":6741,"date":"2026-07-13T14:12:16","date_gmt":"2026-07-13T14:12:16","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=6741"},"modified":"2026-07-22T13:54:30","modified_gmt":"2026-07-22T13:54:30","slug":"drug-related-deaths-in-bulgaria-data-from-national-registry-trend","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/drug-related-deaths-in-bulgaria-data-from-national-registry-trend\/","title":{"rendered":"Drug-related deaths in Bulgaria over the period 2012 – 2025 (data from National Registry)"},"content":{"rendered":"\n
\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
Prevalence of psychoactive substance use
Prevalence of medication use
Prevalence of drug use
Drug Prevention<\/a><\/strong><\/td>		Treatment Supply<\/a>
Treatment Demand
Health consequences<\/a>
Harm reduction<\/a><\/strong><\/td>		Drug-related crimes<\/a>
Drug market<\/a>
Drug use and prison<\/a>
Monitoring of publications<\/a>
Attitudes to legal framework changes<\/a><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Database (1990 – 2025).xlsx<\/a><\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Drug-related deaths in Bulgaria over the period 2012 – 2025 (total)<\/strong><\/p>\n\n\n\n

<\/td>2012<\/strong><\/td>2013<\/strong><\/td>2014<\/strong><\/td>2015<\/strong><\/td>2016<\/strong><\/td>2017<\/strong><\/td>2018<\/strong><\/td>2019<\/strong><\/td>2020<\/strong><\/td>2021<\/strong><\/td>2022<\/strong><\/td>2023<\/strong><\/td>2024<\/strong><\/td>2025<\/strong><\/td><\/tr>
Number of drug-related deaths<\/strong><\/td>30<\/strong><\/td>21<\/strong><\/td>15<\/strong><\/td>17<\/strong><\/td>22<\/strong><\/td>18<\/strong><\/td>24<\/strong><\/td>11<\/strong><\/td>24<\/strong><\/td>20<\/strong><\/td>20<\/strong><\/td>16<\/strong><\/td>48<\/strong><\/td>30<\/strong><\/td><\/tr>
Rates per 100,000 population<\/td>0.41<\/td>0.29<\/td>0.21<\/td>0.24<\/td>0.31<\/td>0.25<\/td>0.34<\/td>0.16<\/td>0.35<\/td>0.29<\/td>0.31<\/td>0.25<\/td>0.75<\/td>0.47<\/td><\/tr>
of which: <\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
number of cases with opioids<\/td><\/td>9<\/td>5<\/td>9<\/td>13<\/td>5<\/td>11<\/td>3<\/td>2<\/td>9<\/td>12<\/td>7<\/td>17<\/td>6<\/td><\/tr>
By ICD-10 Codes (number of cases):<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
F11-F19 <\/td>2<\/td>2<\/td>0<\/td>1<\/td>5<\/td>0<\/td>2<\/td>1<\/td>1<\/td>2<\/td>3<\/td>2<\/td>3<\/td>0<\/td><\/tr>
X41 <\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>3<\/td>3<\/td>0<\/td>0<\/td>3<\/td>1<\/td><\/tr>
X42 <\/td>13<\/td>17<\/td>10<\/td>15<\/td>13<\/td>16<\/td>17<\/td>8<\/td>14<\/td>11<\/td>11<\/td>8<\/td>27<\/td>18<\/td><\/tr>
X61<\/td>4<\/td>0<\/td>0<\/td>0<\/td>1<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
X62<\/td>2<\/td>0<\/td>1<\/td>0<\/td>1<\/td>0<\/td>2<\/td>0<\/td>0<\/td>2<\/td>0<\/td>0<\/td>1<\/td>1<\/td><\/tr>
Y12<\/td>8<\/td>2<\/td>4<\/td>1<\/td>2<\/td>1<\/td>3<\/td>2<\/td>6<\/td>2<\/td>6<\/td>6<\/td>14<\/td>10<\/td><\/tr>
By age groups<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
< 20<\/td>3<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>1<\/td>1<\/td><\/tr>
20-24<\/td>4<\/td>2<\/td>2<\/td>2<\/td>0<\/td>0<\/td>0<\/td>0<\/td>2<\/td>2<\/td>0<\/td>1<\/td>4<\/td>0<\/td><\/tr>
25-29<\/td>8<\/td>6<\/td>3<\/td>1<\/td>3<\/td>2<\/td>4<\/td>4<\/td>3<\/td>1<\/td>2<\/td>1<\/td>1<\/td>3<\/td><\/tr>
30-34<\/td>5<\/td>8<\/td>7<\/td>6<\/td>8<\/td>2<\/td>6<\/td>7<\/td>2<\/td>6<\/td>5<\/td>2<\/td>3<\/td>5<\/td><\/tr>
35-39<\/td>3<\/td>3<\/td>2<\/td>6<\/td>7<\/td>9<\/td>8<\/td>0<\/td>12<\/td>3<\/td>7<\/td>4<\/td>12<\/td>6<\/td><\/tr>
40-44<\/td>2<\/td>1<\/td>1<\/td>1<\/td>1<\/td>3<\/td>3<\/td>0<\/td>4<\/td>2<\/td>3<\/td>7<\/td>15<\/td>11<\/td><\/tr>
45-49<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>4<\/td>0<\/td>1<\/td>10<\/td>3<\/td><\/tr>
50-54<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td><\/tr>
55-59<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>1<\/td><\/tr>
60-64<\/td>0<\/td>1<\/td>0<\/td>1<\/td>2<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td><\/tr>
>= 65<\/td>4<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>3<\/td>0<\/td>0<\/td>2<\/td>2<\/td>0<\/td>0<\/td>0<\/td><\/tr>
Mean age<\/strong><\/td>35.8<\/td>32.4<\/td>27.7<\/td>34.7<\/td>38.3<\/td>34.9<\/td>39.3<\/td>30.4<\/td>33.9<\/td>40.4<\/td>40.6<\/td>37.7<\/td>39.1<\/td>37.9<\/td><\/tr>
Number of cases by place of death<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
At home<\/td>13<\/td>11<\/td>7<\/td>8<\/td>13<\/td>11<\/td>10<\/td>7<\/td>13<\/td>8<\/td>6<\/td><\/td><\/td><\/td><\/tr>
In treatment facility<\/td>6<\/td>5<\/td>1<\/td>6<\/td>4<\/td>4<\/td>6<\/td>1<\/td>4<\/td>6<\/td>8<\/td><\/td><\/td><\/td><\/tr>
Other place<\/td>11<\/td>5<\/td>7<\/td>3<\/td>5<\/td>3<\/td>8<\/td>3<\/td>7<\/td>6<\/td>6<\/td><\/td><\/td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

F11-F19 – Mental and behavioural disorders due to use of psychoactive substances.<\/p>\n\n\n\n

X41 – Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified.<\/p>\n\n\n\n

X42 – Accidental poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified.<\/p>\n\n\n\n

X61 – Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified.<\/p>\n\n\n\n

X62 – Intentional self-poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified.<\/p>\n\n\n\n

Y12 – Poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified, undetermined intent.<\/p>\n\n\n\n

Drug-related deaths in Bulgaria over the period 2012 – 2025 (males)<\/strong><\/p>\n\n\n\n

<\/td>2012<\/strong><\/td>2013<\/strong><\/td>2014<\/strong><\/td>2015<\/strong><\/td>2016<\/strong><\/td>2017<\/strong><\/td>2018<\/strong><\/td>2019<\/strong><\/td>2020<\/strong><\/td>2021<\/strong><\/td>2022<\/strong><\/td>2023<\/strong><\/td>2024<\/strong><\/td>2025<\/strong><\/td><\/tr>
Number of drug-related deaths<\/strong><\/td>23<\/strong><\/td>18<\/strong><\/td>14<\/strong><\/td>15<\/strong><\/td>18<\/strong><\/td>15<\/strong><\/td>18<\/strong><\/td>11<\/strong><\/td>21<\/strong><\/td>18<\/strong><\/td>17<\/strong><\/td>15<\/strong><\/td>42<\/strong><\/td>26<\/strong><\/td><\/tr>
Rates per 100,000 population<\/td>0.65<\/td>0.51<\/td>0.40<\/td>0.43<\/td>0.52<\/td>0.44<\/td>0.53<\/td>0.33<\/td>0.63<\/td>0.54<\/td>0.55<\/td>0.48<\/td>1.36<\/td>0.84<\/td><\/tr>
of which:<\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
number of cases with opioids<\/td><\/td>8<\/td>5<\/td>7<\/td>11<\/td>3<\/td>7<\/td>3<\/td>1<\/td>7<\/td>9<\/td>6<\/td>15<\/td>4<\/td><\/tr>
By ICD-10 Codes (number of cases):<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
F11-F19 <\/td>1<\/td>1<\/td>0<\/td>1<\/td>3<\/td>0<\/td>1<\/td>1<\/td>1<\/td>2<\/td>2<\/td>2<\/td>3<\/td>0<\/td><\/tr>
X41 <\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>3<\/td>3<\/td>0<\/td>0<\/td>3<\/td>1<\/td><\/tr>
X42 <\/td>12<\/td>15<\/td>9<\/td>13<\/td>11<\/td>14<\/td>14<\/td>8<\/td>14<\/td>11<\/td>11<\/td>7<\/td>24<\/td>16<\/td><\/tr>
X61<\/td>1<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
X62<\/td>1<\/td>0<\/td>1<\/td>0<\/td>1<\/td>0<\/td>1<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>1<\/td>1<\/td><\/tr>
Y12<\/td>8<\/td>2<\/td>4<\/td>1<\/td>2<\/td>1<\/td>2<\/td>2<\/td>3<\/td>1<\/td>4<\/td>6<\/td>11<\/td>8<\/td><\/tr>
By age groups<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
< 20<\/td>2<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
20-24<\/td>4<\/td>2<\/td>1<\/td>2<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>2<\/td>0<\/td>1<\/td>4<\/td>0<\/td><\/tr>
25-29<\/td>7<\/td>4<\/td>3<\/td>1<\/td>3<\/td>1<\/td>2<\/td>4<\/td>2<\/td>1<\/td>1<\/td>1<\/td>1<\/td>3<\/td><\/tr>
30-34<\/td>5<\/td>7<\/td>7<\/td>6<\/td>8<\/td>2<\/td>5<\/td>7<\/td>2<\/td>5<\/td>5<\/td>2<\/td>3<\/td>5<\/td><\/tr>
35-39<\/td>3<\/td>3<\/td>2<\/td>6<\/td>6<\/td>9<\/td>6<\/td>0<\/td>11<\/td>3<\/td>7<\/td>4<\/td>11<\/td>3<\/td><\/tr>
40-44<\/td>1<\/td>1<\/td>1<\/td>0<\/td>0<\/td>2<\/td>3<\/td>0<\/td>4<\/td>2<\/td>2<\/td>6<\/td>11<\/td>11<\/td><\/tr>
45-49<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>4<\/td>0<\/td>1<\/td>10<\/td>3<\/td><\/tr>
50-54<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td><\/tr>
55-59<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>1<\/td><\/tr>
60-64<\/td>0<\/td>1<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td><\/tr>
>= 65<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>2<\/td>0<\/td>0<\/td>1<\/td>1<\/td>0<\/td>0<\/td>0<\/td><\/tr>
Mean age<\/strong><\/td>29.8<\/td>33.1<\/td>33.7<\/td>32.3<\/td>35.0<\/td>36.2<\/td>39.7<\/td>30.4<\/td>34.7<\/td>38.5<\/td>39.1<\/td>37.4<\/td>39.5<\/td>38.8<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Drug-related deaths in Bulgaria over the period 2012 – 2025 (females)<\/strong><\/p>\n\n\n\n

<\/td>2012<\/strong><\/td>2013<\/strong><\/td>2014<\/strong><\/td>2015<\/strong><\/td>2016<\/strong><\/td>2017<\/strong><\/td>2018<\/strong><\/td>2019<\/strong><\/td>2020<\/strong><\/td>2021<\/strong><\/td>2022<\/strong><\/td>2023<\/strong><\/td>2024<\/strong><\/td>2025<\/strong><\/td><\/tr>
Number of drug-related deaths<\/strong><\/strong><\/td>7<\/strong><\/td>3<\/strong><\/td>1<\/strong><\/td>2<\/strong><\/td>4<\/strong><\/td>3<\/strong><\/td>6<\/strong><\/td>0<\/strong><\/td>3<\/strong><\/td>2<\/strong><\/td>3<\/strong><\/td>1<\/strong><\/td>6<\/strong><\/td>4<\/strong><\/td><\/tr>
Rates per 100,000 population<\/td>0.19<\/td>0.08<\/td>0.03<\/td>0.05<\/td>0.11<\/td>0.08<\/td>0.17<\/td>–<\/td>0.08<\/td>0.06<\/td>0.09<\/td>0.03<\/td>0.18<\/td>0.12<\/td><\/tr>
of which:<\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
number of cases with opioids<\/td><\/td>1<\/td>0<\/td>2<\/td>2<\/td>2<\/td>4<\/td>0<\/td>1<\/td>2<\/td>3<\/td>1<\/td>2<\/td>2<\/td><\/tr>
By ICD-10 Codes (number of cases):<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
F11-F19 <\/td>1<\/td>1<\/td>0<\/td>0<\/td>2<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td><\/tr>
X41 <\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
X42 <\/td>1<\/td>2<\/td>1<\/td>2<\/td>2<\/td>2<\/td>3<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>3<\/td>2<\/td><\/tr>
X61<\/td>3<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
X62<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
Y12<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>3<\/td>1<\/td>2<\/td>0<\/td>3<\/td>2<\/td><\/tr>
By age groups<\/strong><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/td><\/tr>
< 20<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>1<\/td><\/tr>
20-24<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
25-29<\/td>1<\/td>2<\/td>0<\/td>0<\/td>0<\/td>1<\/td>2<\/td>0<\/td>1<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td><\/tr>
30-34<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
35-39<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>2<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>1<\/td>3<\/td><\/tr>
40-44<\/td>1<\/td>0<\/td>0<\/td>1<\/td>1<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>1<\/td>1<\/td>4<\/td>0<\/td><\/tr>
45-49<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
50-54<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
55-59<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
60-64<\/td>0<\/td>0<\/td>0<\/td>1<\/td>1<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td>0<\/td><\/tr>
>= 65<\/td>4<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td>1<\/td>0<\/td>0<\/td>0<\/td><\/tr>
Mean age<\/strong><\/td>55.5<\/td>28.3<\/td>25.0<\/td>53.0<\/td>53.0<\/td>28.7<\/td>38.3<\/td>–<\/td>30.7<\/td>53.5<\/td>48.3<\/td>40.0<\/td>36.5<\/td>32.0<\/td><\/tr><\/tbody><\/table>
Source: National Statistical Institute<\/em><\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"

Prevalence of psychoactive substance usePrevalence of medication usePrevalence of drug useDrug Prevention Treatment SupplyTreatment DemandHealth consequencesHarm reduction Drug-related crimesDrug marketDrug use and prisonMonitoring of publicationsAttitudes to legal framework changes Database (1990 – 2025).xlsx Drug-related deaths in Bulgaria over the period 2012 – 2025 (total) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84,87],"tags":[],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/6741"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=6741"}],"version-history":[{"count":6,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/6741\/revisions"}],"predecessor-version":[{"id":8021,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/6741\/revisions\/8021"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=6741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=6741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=6741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}